Blog
RSS FeedPosted by Michael Wonder on 10 Mar 2020
Inappropriate use of progression-free survival in cancer drug approvals
10 March 2020 - New drugs should be judged on overall survival or quality of life, preferably both. ...
Posted by Michael Wonder on 16 Aug 2019
Brexit's disruptive impact on U.K. and European prescription drug market
15 August 2019 - The new Prime Minister of Britain, Boris Johnson, is one of the more strident Brexiteers. He's ...
Posted by Michael Wonder on 26 Mar 2019
EMA tells pharma companies to continue to prepare for UK’s withdrawal
25 March 2019 - With an extension in place that will push the UK's withdrawal from the EU back to ...
Posted by Michael Wonder on 22 Jan 2019
Sanofi UK marketing authorisation granted for Sanofi Pasteur’s trivalent influenza vaccine (split virion, inactivated) high dose (TIV high dose)
21 January 2019 - UK is the only European country where TIV high dose is approved. ...
Posted by Michael Wonder on 16 Jan 2019
EFPIA response to the UK parliament’s decision to reject the Brexit withdrawal agreement and political declaration
15 January 2019 - EFPIA notes the UK parliament’s decision to reject the Brexit withdrawal agreement and political declaration. ...
Posted by Michael Wonder on 12 Jan 2019
Time running out for ‘no-deal’ Brexit medicines laws
11 January 2019 - Needs parliament clearance before 29 March. ...
Posted by Michael Wonder on 05 Dec 2018
Europe’s drug regulator is backing away from the U.K.
4 December 2018 - Potential split sparks concern about delays, patient access. ...
Posted by Michael Wonder on 25 Oct 2018
Fast-track flu vaccine raises hopes for quicker drugs approvals
24 October 2018 - Post-Brexit registrations could be ‘five months faster’, says medicines regulator. ...
Posted by Michael Wonder on 03 Sep 2018
Britain loses medicines contracts as EU body anticipates Brexit
3 September 2018 - European Medicines Agency ends pharma evaluations work and moves contracts to bloc. ...
Posted by Michael Wonder on 16 Aug 2018
European drug agency loses 30% of staff in planned move to Amsterdam
16 August 2018 - The EMA is counting the cost of the UK’s decision to leave the European Union, which ...
Posted by Michael Wonder on 06 Aug 2018
MHRA clarifies post-Brexit clinical trials rules
8 August 2018 - The MHRA has clarified how the UK’s clinical trials rules will function in partnership with the ...
Posted by Michael Wonder on 01 Aug 2018
Brexit preparedness: EMA to further temporarily scale back and suspend activities
1 August 2018 - Next phase of business continuity plan aimed at securing essential public and animal health activities ...
Posted by Michael Wonder on 10 Jul 2018
EMA identifies gaps in industry preparedness for Brexit
10 July 2018 - Survey indicates that some companies need to step up efforts to ensure medicine supply in the ...
Posted by Michael Wonder on 19 Apr 2018
Industry fears disruption as EU excludes UK from drug approvals
18 April 2018 - A European decision to exclude Britain from the EU’s drug approval system from March 30 2019 - ...
Posted by Michael Wonder on 11 Apr 2018
Redistribution of UK’s portfolio of centrally authorised products
11 April 2018 - Assignment of new rapporteurs and co-rapporteurs completed. ...